Mexico: COFECE asked to investigate corruption in pharmaceuticals

Alfonso Ramírez Cuellar, President of the Budget and Public Accounts Committee of the Chamber of Deputies of Mexico, has asked the Federal Commission for Economic Competition (COFECE) to begin investigations to detect pharmaceutical companies involved in corruption cases, in order to prevent their participation in future tenders.

Some pharmaceutical companies, including marketers and distributors of drugs, have been involved in crimes such as bribery, data omission, price manipulation and monopolistic practices, affecting consumers across the country.

At the beginning of 2018, COFECE declared that it had evidence of unauthorized mergers in this market, including medicines, hygiene products and personal care products.
Full Content: El Sol de México

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.